COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 21 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $90,000 | – | 13,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $3,253,628 | 6.54% |
| VILLERE ST DENIS J & CO LLC | 300,173 | $1,671,963 | 0.14% |
| PINNACLE ASSOCIATES LTD | 478,309 | $2,664,181 | 0.05% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 45,050 | $254 | 0.01% |
| FNY Investment Advisers, LLC | 1,539 | $8 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,140 | $130,278 | 0.00% |
| BROWN ADVISORY INC | 74,836 | $416,837 | 0.00% |
| Geneos Wealth Management Inc. | 750 | $4,223 | 0.00% |
| Focused Wealth Management, Inc | 242 | $1,348 | 0.00% |
| UBS Group AG | 5,690 | $31,693 | 0.00% |